The cumulative effect analyses by considering multiple CpG sites in each gene also demonstrated an obvious difference of methylation levels between normal and cancer samples (CASZ1: P 0.001, CDH13: P 0.001, ING2: P 0.001) (Table 6). This evidence concerns the gene ING2 and cancer.